CompletedNot Applicable

GonoScreen: Efficacy of Screening STIs in MSM

Belgium1,014 participantsStarted 2020-09-21

Plain-language summary

A Multicentre, controlled, randomized trial of 3 site (urethra, pharynx and rectum) sampling performed every 3 months (3x3) for Neisseria gonorrhoea (Ng)/Chlamydia trachomatis (Ct) screening (comparator) vs. no screening (intervention).

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Able and willing to provide informed consent * Men (born as males) and transwomen aged 18 or more * Has had sex\*\* with another man in the last 12 months * Enrolled in Belgian PrEP program at ITM/HSP/EH/CHU/UZG with approval for TDF/FTC (Tenofovir disoproxil fumarate/Emtricitabine) reimbursement from a Belgian Medical Aid * Willing to comply with the study procedures and to attend the clinic for the 3-monthly visits Exclusion Criteria: * Enrolment in another interventional trial * Tests HIV-positive at screening * Symptoms of proctitis or urethritis

What they're measuring

Incidence Rate of Ng Plus Ct Detected at Any Site Whilst Individuals Are Screened vs. Not Screened

Timeframe: 12 months

Trial details

NCT IDNCT04269434

SponsorInstitute of Tropical Medicine, Belgium

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-08-31

Results submitted2023-04-03

View on ClinicalTrials.gov More Neisseria Gonorrhoeae Infection trials